Aziyo Biologics Inc. (AZYO)

AI Score

Unlock

1.49

0.03 (2.05%)

At close: Sep 06, 2023, 7:59 PM

Aziyo Biologics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q3 2020	Q2 2020	Q4 2019
Period Ending	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Dec 31, 2019
Cash & Equivalents	14.52M	9.3M	11.79M	16.99M	8.1M	16.51M	22.07M	30.43M	22.54M	28.3M	30.5M	39.53M	1.64M	990K	2.48M
Short-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	2.6M	n/a	n/a	n/a	89K	76K	76K	76K	76K	76K	76K	76K	76K	76K	76K
Receivables	2.88M	6.32M	7.33M	6.83M	7.16M	6.65M	6.01M	6M	5.52M	7.75M	8.76M	7.17M	7.1M	5.87M	7.23M
Inventory	6.5M	9.27M	11.05M	10.05M	10.19M	9.7M	9.86M	9.55M	9.83M	10.34M	10.22M	10.12M	9.79M	9.62M	7.19M
Other Current Assets	15.22M	11.24M	13.29M	16.83M	18.2M	1.85M	3.03M	1.49M	1.28M	1.76M	2.52M	3.27M	3.79M	1.2M	1.44M
Total Current Assets	39.13M	36.13M	43.47M	50.7M	43.66M	34.68M	41.08M	47.43M	39.25M	48.22M	51.91M	59.71M	22.21M	17.73M	18.45M
Property-Plant & Equipment	330K	2.83M	2.94M	3.07M	1.36M	1.33M	1.16M	1.2M	1.26M	1.24M	1.21M	1.16M	1.14M	826K	988K
Goodwill & Intangibles	12.52M	13.37M	14.22M	15.07M	15.92M	16.77M	17.62M	18.47M	19.32M	20.17M	21.02M	21.86M	22.71M	23.56M	25.26M
Total Long-Term Assets	15.45M	16.2M	17.16M	18.14M	17.37M	18.17M	18.85M	19.74M	20.65M	21.48M	22.3M	23.1M	23.93M	24.46M	26.33M
Total Assets	54.58M	52.33M	60.63M	68.84M	61.02M	52.85M	59.93M	67.17M	59.9M	69.7M	74.21M	82.81M	46.14M	42.2M	44.77M
Account Payables	2.96M	3.23M	3.5M	2.33M	2.62M	1.76M	1.72M	1.58M	1.69M	1.63M	1.97M	2.05M	3.25M	2M	2.49M
Deferred Revenue	n/a	14.18M	n/a	n/a	n/a	8K	8.63M	5K	110K	251K	392K	533K	537K	562K	650K
Short-Term Debt	399K	620K	588K	n/a	n/a	14.51M	14.22M	15.57M	10.02M	10.41M	14.82M	15.57M	8.76M	8.52M	5.92M
Other Current Liabilities	41.38M	39.02M	37.34M	40.29M	37.55M	18.47M	11.38M	8.84M	10.7M	11.3M	7.59M	8.62M	13.05M	9.96M	9.21M
Total Current Liabilities	44.74M	42.87M	41.42M	42.62M	40.17M	34.75M	27.32M	26M	22.51M	23.6M	24.77M	26.78M	25.59M	21.04M	18.27M
Long-Term Debt	30.75M	31.24M	31.17M	25.22M	31.45M	18.57M	25.28M	10.41M	12.05M	13.68M	15.53M	17.81M	21.2M	23.43M	19.61M
Other Long-Term Liabilities	8.57M	351K	207K	6.04M	86K	899K	771K	17.24M	16.55M	16.59M	16.63M	16.63M	73.26M	16.68M	61.29M
Total Long-Term Liabilities	39.32M	31.59M	31.38M	31.26M	31.54M	19.47M	26.05M	27.65M	29.53M	31.14M	32.99M	35.2M	95.46M	40.73M	81.61M
Total Liabilities	84.05M	74.46M	72.81M	73.87M	71.7M	54.22M	53.37M	53.65M	52.04M	54.73M	57.77M	61.98M	121.05M	61.77M	99.88M
Total Debt	31.15M	26.26M	35.69M	34.89M	27.75M	29.37M	22.98M	25.98M	22.06M	24.09M	30.35M	33.38M	32.71M	31.96M	25.53M
Common Stock	23K	16K	16K	16K	13K	13K	13K	13K	10K	10K	10K	10K	1K	7K	1K
Retained Earnings	-166.33M	-156.58M	-145.96M	-137.99M	-132.55M	-122.64M	-113.24M	-105.09M	-96.03M	-87.71M	-85.33M	-80.26M	-74.91M	-66.68M	-56.94M
Comprehensive Income	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-85.33M	-80.26M	-74.91M	-66.68M	-56.94M
Shareholders Equity	-29.47M	-22.13M	-12.18M	-5.03M	-10.68M	-1.37M	6.56M	13.52M	7.86M	14.97M	16.44M	20.83M	-74.9M	-19.58M	-55.11M
Total Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a